clinical trial · NCT05347095
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
Fistulizing Crohns DiseasePerianal Crohns DiseaseGuselkumabPlacebo
brief summary
The purpose of this study to evaluate the clinical efficacy of guselkumab in fistulizing, perianal Crohn's disease and to assess the overall safety of guselkumab.
started
Sep 27, 2022
primary completion
Mar 25, 2027
completion
Mar 25, 2027
last updated
Jul 6, 2026
official title
A Phase 3, Randomized, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol